Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-11-13
2007-11-13
Huff, Sheela J. (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387700, C530S387900
Reexamination Certificate
active
10405123
ABSTRACT:
An antibody fragment and methods of utilizing same are provided. The antibody fragment includes an antigen binding region capable of binding an extracellular portion of a P-glycoprotein thereby at least partially inhibiting drug efflux activity in multidrug resistant cells.
REFERENCES:
patent: 3791932 (1974-02-01), Schuurs et al.
patent: 3839153 (1974-10-01), Schuurs et al.
patent: 3850752 (1974-11-01), Schuurs et al.
patent: 3853987 (1974-12-01), Dreyer
patent: 3867517 (1975-02-01), Ling
patent: 3879517 (1975-04-01), Meyn et al.
patent: 3901654 (1975-08-01), Gross
patent: 3935074 (1976-01-01), Rubenstein et al.
patent: 3984533 (1976-10-01), Uzgiris
patent: 3996345 (1976-12-01), Ullman et al.
patent: 4034074 (1977-07-01), Miles
patent: 4098876 (1978-07-01), Piasio et al.
patent: 4666828 (1987-05-01), Gusella
patent: 4683202 (1987-07-01), Mullis
patent: 4801531 (1989-01-01), Frossard
patent: 4837306 (1989-06-01), Ling et al.
patent: 4866042 (1989-09-01), Neuwelt
patent: 4879219 (1989-11-01), Wands et al.
patent: 5011771 (1991-04-01), Bellet
patent: 5192659 (1993-03-01), Simons
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5272057 (1993-12-01), Smulson et al.
patent: 5281521 (1994-01-01), Trojanowski
patent: 5403484 (1995-04-01), Ladner et al.
patent: 5403574 (1995-04-01), Piwnica-Worms
patent: 5427908 (1995-06-01), Dower et al.
patent: 5434075 (1995-07-01), Mechetner et al.
patent: 5464764 (1995-11-01), Capecchi
patent: 5487992 (1996-01-01), Capecchi
patent: 5516637 (1996-05-01), Huang et al.
patent: 5543423 (1996-08-01), Zelle et al.
patent: 5556856 (1996-09-01), Engel et al.
patent: 5571698 (1996-11-01), Ladner et al.
patent: 5580717 (1996-12-01), Dower et al.
patent: 5658727 (1997-08-01), Barbas et al.
patent: 5698426 (1997-12-01), Huse
patent: 5733743 (1998-03-01), Johnson et al.
patent: 5750753 (1998-05-01), Kimae et al.
patent: 5766946 (1998-06-01), Cianfriglia
patent: 5780225 (1998-07-01), Wigler et al.
patent: 5821047 (1998-10-01), Garrard et al.
patent: 5932447 (1999-08-01), Siegall
patent: 5969108 (1999-10-01), McCafferty et al.
patent: 6479639 (2002-11-01), Metchetner et al.
patent: 94/10198 (1994-05-01), None
Mayforth Designing Antibodies, Academic Press p. 106-107 (1993).
Niv et al Int. J. Cancer vol. 94 p. 864-872 (2001).
Roninson et al. “Amplification Of Specific DNA Sequences Correlates With Multi-Drug Resistance in Chineses Hamster Cells”, Nature, 309: 626-628, 1984.
Goldstein et al. “Expression of a Multidrug Resistance Gene in Human Cancers”, Journal of the National Cancer Institute, 81: 116-124, 1989.
Tsuruo et al. “Overcoming of Vincristine Resistance in P388 Leukemia In Vivo and In Vitro Through Enhanced Cytotoxicity of Vincristine and Vinblastine by Verapamil”, Cancer Res., 41: 1967-1972, 1981.
Hamada et al. “Functional Role for the 170- to 180-kDa Glycoprotein Specific to Drug-Resistant Tumor Cells as Revealed By Monoclonal Antibodies”, Proc. Natl. Acad. Sci. USA, 83: 7785-7789, 1986.
Jain “Delivery of Molecular Medicine to Solid Tumors”, Science, 271:1079-1080, 1996.
Huston et al. “Protein Engineering of Antibody Binding Sites: Recovery of Specific Activity in an Anti-Digoxin Single-Chain Fv. Analogue Produced inEscherichia coli.”, Proc. Natl. Acad. Sci. USA 85: 5879-5883, 1996.
Hoogenboom et al. “Multi-Subunit Proteins On The Surface Of Filamentous Phage: Methodologies For Displaying Antibody (Fab) Heavy And Light Chains”,Nucleic Acids Research, 19(15): 4133-4137, 1991.
Eva et al. “Cellular Genes Analogous to Retroviral onc Genes are Transcribed in Human Tumour Cells”, Nature, 295: 116-119, 1982.
Denkberg et al. “Direct Visualization of Distinct T Cell Epitopes Derived from a Melanoma Tumor-Associated Antigen by Using Human Recombiant Antibodies with MHC-Restricted T Cell Receptor-Like Specificity”, Proc. Natl. Acad. Sci., 99(14): 9421-9426, 2002.
Akiyama et al. “Isolation and Genetic Characterization of Human KB Cell Lines Resistant to Multiple Drugs”, Somaic Cell and Molecular Genetics 11(2): 117-126, 1985.
Sharma et al. “A Phenotype Conferring Selective Resistance to Lipophilic Antifolates in Chinese Hamster Oval Cells”, Cancer Res., 51: 2949-2959, 1991.
Brisson et al. “Expresion Of A Bacterial Gene In Plants By Using A Viral Vector”, Nature, 310:511-514, 1984.
Brogli et al. “Light-Regulated Expression Of A Pea Ribulose-1,5-Bisphosphate Carboxylase Small Subunit Gene In Transformed Plant Cells”, Science, 224 :838-843, 1984.
Cinciarelli et al. “Characterization By Somatic Cell Genetics Of A Monoclonal Antibody To The MDR1 Gene Product (P-Glycoprotein): Determination Of P-Glycoprotein Expression In Multi-Drug-Resistant KB And CEM Cell Variants”, Int. J. Cancer, 47:533-543, 1991.
Clackson et al., “Making Antibody Fragments using Phage Display Libraries”, Nature, 352: 624-628, 1991.
Cole et al. “Pharmcological Characterization Of Multidrug Resistant MRP-Transfected Human T%umor Cells”, Cancer Research, 54: 5902-5910, 1994.
Gurley et al. “Upstream Sequences Required For Efficient Expression Of A Soybean Heat shock Gene”. Molecular and Cellular Biology, 6(2): 559-565, 1986.
Hamada et al. “Mouse-Human Chimeric Antibody Against The Multidrug Transporter P-Glycoprotein”, Cancer Research, 50: 3167-3171, 1990.
Lej et al. “Charcterization Of The Erwinia Carotovora PelB Gene And Its Product Pectate Lyase”, Journal of Bacteriology, 169(9): 4379-4383, 1987.
Meyers et al. “Characterization Of Monoclonal Antibodies Recognizing A Mr 180,000 P-Glycoprotein: Differntial Expression Of the Mr 180,000 and Mr170,000 P-Glycoproteins In Multidrug-Resistant Human Tumor Cells”, Cancer Research, 49:3209-3214, 1989.
Pearson et al. “Reversal Of Drug Resistance In A Human Colon Cancer Xenograft Expressionb MDR1 Complementary DNA By In Vivo Administation Of MRK-16 Monoclonal Antibody”, Journal of the National Cancer Institute, 83(19):1386-1391, 1991.
Takamutsu et al. “Expression Of Bacterial Chloramphenicol Acetyltransferase Gene In Tobacco Plants Mediated By TMV-RNA”, EMBO Journal, 6(2): 307-311, 1987.
Coruzzi et al. “Tissue-Specific And Light-Regulated Expression Of A Pea Nuclear Gene Encoding The Small Subunit of Ribulose-1,5-Bisphosphate Carboxylase”, EMBO Journal; 3(8):1671-1680, 1984.
von Heijne “Signal Sequences The Limits Of Variation”,Journal of Molecular Biology, 184: 99-105, 1985.
Yakota et al. “Rapid Tumor Penetration Of A Single-Chain Fv And Comparison With Other Immunoglobulin Forms”, Cancer Res., 52:3402-3408, 1992.
Haus-Cohen Maya
Reiter Yoram
Huff Sheela J.
Technion Research & Development Foundation Ltd.
LandOfFree
Antibody fragment capable of modulating multidrug resistance... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody fragment capable of modulating multidrug resistance..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody fragment capable of modulating multidrug resistance... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3816696